Geremia B Bolli

30PUBLICATIONS
29CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsNutrigenomics and personalised nutritionTissue engineeringIndustrial biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 28, 2026
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus.

|Nov 03, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.

Wolfgang Landgraf, David R Owens, Brian M Frier

|Jul 18, 2025
An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes.

Geremia B Bolli, Francesca Porcellati, Paola Lucidi

|Mar 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.

Geremia B Bolli, Philip D Home, Francesca Porcellati

|Jun 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis.

Wolfgang Landgraf, David R Owens, Brian M Frier

|Oct 20, 2023
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.

Wolfgang Landgraf, David R Owens, Brian M Frier

Pageof 5

Frequent Collaborators

10 joint publications

David R Owens

7 joint publications

Carmine G Fanelli

6 joint publications

Brian M Frier

6 joint publications

Wolfgang Landgraf